Managing Ulcerative Colitis Flare-Ups
Severity Assessment and Initial Approach
- The American Gastroenterological Association recommends using biomarkers such as fecal calprotectin >150 mg/g, elevated fecal lactoferrin, or elevated CRP to guide treatment decisions in patients with moderate to severe symptoms, as these biomarkers reliably indicate moderate to severe endoscopic inflammation 1, 2
- Hospitalization is recommended for severe flares requiring joint management by gastroenterology and colorectal surgery, with monitoring of vital signs four times daily and stool charts documenting number, character, and presence of blood 3, 4
- The European Crohn’s and Colitis Organisation suggests obtaining laboratory studies every 24-48 hours, including CBC, ESR or CRP, electrolytes, albumin, and liver function tests, to assess disease severity and guide treatment decisions 3, 4
Medical Management Algorithm
- The American College of Gastroenterology recommends intravenous corticosteroids, such as hydrocortisone 400 mg/day or methylprednisolone 60 mg/day, as first-line therapy for severe flares, with supportive care including IV fluid and electrolyte replacement, subcutaneous heparin for thromboprophylaxis, and nutritional support if malnourished 3, 4
- Infliximab or cyclosporine are indicated as rescue therapy when patients fail to respond adequately to IV corticosteroids after 3-5 days, according to the British Society of Gastroenterology 6, 5
Critical Pitfalls and Caveats
- The Infectious Diseases Society of America recommends always ruling out infectious causes before attributing symptoms to IBD flare, as superimposed bacterial or viral infections account for a significant proportion of flares, and stool cultures are positive in only 40-60% of infectious colitis cases 6, 5
- Urgent colectomy is indicated if medical rescue therapy fails or in fulminant colitis to prevent critical complications, with a 25-30% chance of needing colectomy during severe flare, according to the American Society of Colon and Rectal Surgeons 3, 4, 5